10-Q: Green Thumb Industries Reports Q2 Net Loss Amid Growth

Green Thumb Industries reported a net loss for Q2 2025, driven by increased expenses and a one-time asset sale loss, despite revenue growth and continued market expansion.

Summary

• Green Thumb Industries reported net revenues of $293.26 million for the three months ended June 30, 2025, a 5% increase from $280.15 million in the same period last year.
• The company experienced a net loss attributable to Green Thumb Industries Inc. of $0.65 million for Q2 2025, a significant decline from a net income of $20.71 million in Q2 2024.
• Gross profit decreased by 3% to $146.26 million in Q2 2025, with gross margin falling to 50% from 54% in Q2 2024, primarily due to price compression.
• Total expenses increased by 11% to $106.82 million in Q2 2025, driven by higher costs associated with ongoing claims, litigation, and new retail store operations.
• A loss of $11.68 million was incurred on the sale of the 'incredibles' intellectual property to Agrify Corporation during Q2 2025.
• Adjusted EBITDA for Q2 2025 was $82.74 million, down 12% from $93.80 million in Q2 2024.
• The effective tax rate for Q2 2025 was 96.7%, significantly higher than 60.4% in Q2 2024, largely due to U.S. Internal Revenue Code Section 280E.
• The company opened 14 new retail stores since June 30, 2024, and acquired three retail stores in Connecticut for $14.30 million in cash.
• Green Thumb repurchased 5,718,000 Subordinate Voting Shares at an average price of $4.34 per share during the six months ended June 30, 2025, with approximately $15.60 million remaining under the repurchase program.

Sentiment

Score: 4

Explanation: While revenue growth and operational cash flow are positive, the significant decline in gross margin, the shift to a net loss for the quarter, and the substantial increase in expenses (including a one-time loss) indicate deteriorating profitability. The high effective tax rate remains a major headwind. The overall financial performance for the period is concerning despite strategic expansion.

Positives

• Net revenues increased by 5% quarter-over-quarter and 3% year-to-date, indicating continued top-line growth.
• The Consumer Packaged Goods segment saw an 8% increase in revenues quarter-over-quarter and 11% year-to-date, demonstrating strong brand performance.
• Expansion of retail footprint with 14 new stores opened and 3 acquired since June 30, 2024, including entry into new adult-use markets like Ohio.
• Cash and cash equivalents increased to $176.92 million as of June 30, 2025, up from $171.69 million at December 31, 2024.
• Net cash flows provided by operating activities increased to $130.67 million for the six months ended June 30, 2025, up from $104.17 million in the prior year period, indicating strong operational cash generation.
• The company is in compliance with all covenants associated with its $150 million syndicated credit facility.

Negatives

• The company reported a net loss of $0.65 million for Q2 2025, a significant reversal from a net income of $20.71 million in Q2 2024.
• Gross margin declined to 50% in Q2 2025 from 54% in Q2 2024, primarily due to price compression in the market.
• Total expenses increased by 11% quarter-over-quarter, outpacing revenue growth.
• A substantial loss of $11.68 million was recognized on the divestiture of the 'incredibles' intellectual property and hemp business.
• Adjusted EBITDA decreased by 12% quarter-over-quarter and 9% year-to-date, indicating a decline in core operating profitability.
• The effective tax rate for Q2 2025 was extremely high at 96.7%, largely due to the impact of IRC Section 280E.
• Working capital decreased by $12.82 million, primarily due to acquisitions and share repurchases.

Risks

• Cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change, impacting operations.
• State regulation of cannabis is uncertain and subject to change, potentially affecting permits and operations.
• The company may face limitations on ownership of cannabis licenses.
• Potential for regulation by the U.S. Food and Drug Administration (FDA) or the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).
• Restricted access to banking and other financial services due to applicable anti-money laundering laws and regulations.
• Difficulties acquiring additional financing in the future.
• Intense competition from both the illicit market and Farm Bill compliant hemp products.
• Dependence on the popularity and consumer acceptance of its brand portfolio.
• Limited trademark protection for cannabis products.
• Unfavorable U.S. tax treatment under IRC Section 280E, leading to significant tax liability.
• Exposure to fraudulent or illegal activity.
• Risks due to industry immaturity or limited comparable, competitive, or established industry best practices.
• Inherent risks in agricultural operations, including crop failure or disease.
• Risk of product liability or similar claims and potential product recalls.
• Adverse impact from rising or volatile energy costs and availability.
• Risks related to information technology systems, potential cyber-attacks, and security breaches.
• Reliance on third-party software providers, with potential for business disruption if systems fail.
• Loss of key personnel experienced in the cannabis industry could negatively affect business.
• Concentrated voting control and capital structure may cause unpredictability.
• Sales of substantial amounts of Subordinate Voting Shares by shareholders could adversely affect the market price.

Future Outlook

The company expects to continue its growth strategy by expanding its Consumer Packaged Goods and Retail footprint within current markets through acquisitions and partnerships, and by scaling resources into new markets. New store opening plans will remain fluid, dependent on market conditions, local licensing, construction, and capital allocation plans. Stock-based compensation expense is expected to continue to increase to support business growth by attracting and retaining talent.

Management Comments

• Management believes the expectations reflected in forward-looking statements are reasonable, but cannot assure they will prove correct.
• The company's new store opening plans will remain fluid depending on market conditions, obtaining local licensing, construction and other permissions and subject to the company's capital allocation plans.
• The company continues to focus on creating sustainable, profitable growth of the company's business while pursuing expansion.
• The company expects to continue to invest considerably in general and administrative expenses, particularly stock-based compensation, to support the business by attracting and retaining top-tier talent.

Industry Context

The U.S. cannabis industry continues to be characterized by state-level legalization and growth, as evidenced by the continued expansion of adult-use markets in New York and Ohio. However, the industry faces persistent challenges including price compression, increased competition, and the significant burden of U.S. federal tax treatment under IRC Section 280E, which severely limits deductible expenses for cannabis businesses. Green Thumb's strategy of vertical integration, combining consumer packaged goods manufacturing with retail operations, is a common approach in this fragmented market to control supply chains and capture value across the cannabis ecosystem.

Corporate Governance

Legal Proceedings

• A court ruled in favor of a plaintiff landlord in a commercial property lease dispute, ordering the company to pay $7.31 million for unpaid rent and an additional $0.91 million for interest and attorney fees, totaling $8.22 million. The company will appeal this Final Judgment in August 2025.

Related Party Transactions

• The company holds a 34% ownership interest in Agrify Corporation and accounts for its investment using the equity method. Benjamin Kovler (CEO) and Armon Vakali (VP) serve on Agrify's Board of Directors.
• The company extended a $10 million convertible secured note to Agrify Corporation on November 5, 2024, maturing November 5, 2025, with a 10% annualized interest rate.
• An additional $27 million in convertible notes were issued to Agrify Corporation on May 22, 2025, due November 22, 2026.
• Green Thumb sold its 'incredibles' brand intellectual property and Farm Bill compliant hemp business (Core Growth LLC) to Agrify for $5.08 million in cash, resulting in an $11.68 million loss on sale. The intellectual property was licensed back to Green Thumb.
• Green Thumb entered into a separate licensing agreement with Agrify associated with its Beboe and RYTHM branded products.
• The company provided management services to Agrify, with $1.34 million owed to Green Thumb as of June 30, 2025.
• Lease expenses of $0.13 million for Q2 2025 and $0.25 million for H1 2025 were recorded with Mosaic Real Estate, LLC, partially owned by the CEO and President. A related party leasing agreement was terminated on December 17, 2024, when the company purchased the leased property for $0.65 million.

Stakeholder Impact

• Shareholders: Experienced a net loss for the quarter and a significant decrease in net income per share, potentially impacting stock price. Share repurchases may offer some support but working capital decreased.
• Employees: Stock-based compensation is expected to increase to attract and retain talent, which is positive for employees. The company employs approximately 4,800 people.
• Customers: Continued expansion of retail stores and product offerings in new and existing markets aims to serve more patients and customers.
• Creditors: The company remains in compliance with debt covenants, indicating ability to meet obligations, though working capital decreased.
• Suppliers: The company's continued growth and expansion suggest ongoing demand for supplies and services.

Next Steps

• Appeal the Final Judgment in the commercial property lease dispute in August 2025.
• Continue to focus on creating sustainable, profitable growth and pursuing expansion.
• Expand Consumer Packaged Goods and Retail footprint within current markets through acquisitions and partnerships.
• Scale resources into new markets, with new store opening plans remaining fluid based on market conditions and licensing.
• Continue to invest in corporate infrastructure and stock-based compensation to attract and retain talent.

Key Dates

Recommendation

While Green Thumb Industries demonstrates continued revenue growth and strategic expansion into new adult-use markets, the significant decline in gross margins due to price compression, the shift to a net loss for the quarter, and the substantial increase in operating expenses (including a one-time asset sale loss and legal judgment) are concerning. The high effective tax rate remains a persistent drag on profitability. However, the company maintains positive cash flow from operations and is actively repurchasing shares, indicating management's confidence and commitment to shareholder returns. For a seasoned investor, the long-term potential of the expanding U.S. cannabis market, coupled with Green Thumb's established footprint and operational cash generation, suggests a 'Hold' position, but with close monitoring of profitability trends and expense management.

Keywords

Cannabis, Marijuana, Multi-state operator, MSO, Cannabis retail, Consumer packaged goods, SEC filing, 10-Q, Financial results, Earnings, Cannabis industry, Green Thumb Industries, GTI, RISE Dispensaries, Adult-use cannabis, Medical cannabis